TOTAL DİZ ARTROPLASTİSİNDE KAN KAYBINI ETKİLEYEN FAKTÖRLER VE ÖNLEYİCİ YÖNTEMLER

Total diz artroplastisi cerrahisi ortalama yaşam süresinin artması ile ülkemizde ve dünyada en sık uygulanancerrahi işlemlerden biri haline gelmiştir. Bu cerrahinin uygulandığı hasta grubu genellikle geriatrik yaş grubundan olduğundan birçok eşlik eden kronik hastalığa sahiptirler. Bu nedenle ameliyat sırasında ve sonrasındakan kaybının nedenlerini anlamak ve önleyici yöntemler geliştirmek önem kazanmaktadır. Böylece ameliyatsonraki hemoglobin değerini olabildiğince yüksek tutarken kan transfüzyonu en düşük düzeyde tutmak hedeflenmektedir. Kan kaybını engelleyici yöntemlerde; hastaya özel risk faktörleri, beklenen kan kaybı ve ko- morbiditelere dayalı bireyselleştirilmiş bir strateji uygulanması son dönemlerde en doğru yöntem olarak kabuledilmiştir. Çeşitli stratejiler ameliyat öncesinde, ameliyat sırasında ve ameliyat sonrasında tek başına ya daberaber kullanılabilmektedir.

Factors Influencing the Blood Loss in Total Knee Arthroplasty and Preventive Measures

Total knee arthroplasty surgery has become one of the most frequently performed surgical procedure byincreasing average life time in our country and the world. This surgery is usually applied to geriatric age group,so many of the patients have accompanying chronic diseases. Therefore, it is important to understand thecauses of perioperative blood loss and develop preventive methods. Thus, it is aimed to keep the hemoglobinvalue as high as possible while performing minimal blood transfusion. An individualized strategy based onpatient specific risk factors and co-morbidities has been considered the most accurate method to achieve thisaim in recent years. Multiple strategies can be used alone or together during perioperative period.

PDF

___

1. Cankaya D, Ozkurt B, Aydin C, Tabak AY. No difference in blood loss between posterior-cruciate-ligament-retaining and posterior-cruciate-ligament-stabilized total knee arthroplasties. Knee Surg Sports Traumatol Arthrosc. 2014;22(8):1865-9.
2. Kalairajah Y, Simpson D, Cossey AJ, Verrall GM, Spriggins AJ. Blood lossafter total knee replacement:effects of computer-assistedsurgery.J Bone Joint Surg Br. 2005;87(11):1480-2.
3. McConnell JS, Shewale S, Munro NA, Shah K, Deakin AH, Kinninmonth AW. Reducing blood loss in primary knee arthroplasty: a prospective randomised controlled trial of tranexamic acid and fibrin spray. Knee. 2012;19(4):2958.
4. Tai TW, Yang CY, Jou IM, Lai KA, Chen CH. Temporary drainage clamping after totalknee arthroplasty: a meta- analysis of randomized controlled trials. J Arthroplasty. 2010;25(8):12405.
5. Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, Cremers S, Abraham IL; OSTHEO Investigation. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003;43(4):459-69.
6. Bierbaum BE, Hill C, Callaghan JJ, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999;81(1):210.
7. Bernard AC, Davenport DL, Chang PK, Vaughan TB, Zwischenberger JB. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg. 2009;208(5):931-7.
8. Bower WF, Jin L, Underwood MJ, Lam YH, Lai PB. Peri- operative blood transfusion increases length of hospital stay and number of post-operative complications in non-cardiac surgical patients. Hong Kong Med J. 2010;16(2):116.
9. Ahmed I, Chan JK, Jenkins P, Brenkel I, Walmsley P. Estimating the transfusion risk following total knee arthroplasty. Orthopedics. 2012;35:e1465-71.
10. Pola E, Papaleo P, Santoliquido A, Gasparini G, Aulisa L, De Santis E. Clinical factors associated with an increased risk of perioperative blood transfusion in nonanemic patients undergoing total hip arthroplasty. J Bone Joint Surg Am. 2004;86(1):57-61.
11. Spahn D. Anaemia and patient blood management in hip and knee surgery. Anaesthesiology. 2010;113(2):482-95.
12. Arthroplasty Society of Australia. Guidelines for venous thrombotic episode prophylaxis for hip and knee arthroplasty. Australian Orthopaedic Association 2010.
13. Oscarsson A, Gupta A, Fredrikson, M Järhult J, Nyström M, Pettersson E, Darvish B, Krook H, Swahn E, Eintrei C. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br. J. Anaesth. 2010;104:305-12.
14. Cushner FD, Scott WN, Scuderi G, Hill K, Insall JN. Blood loss and transfusion rates in bilateral total knee arthroplasty. J Knee Surg 2005;18:102-7.
15. Moonen AF, Knoors NT, van Os JJ, Verburg AD, Pilot P. Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: A prospective randomized clinical trial. Transfusion 2007; 47: 379-84
16. Krajewski K, Ashley RK, Pung N, Wald S, Lazareff J, Kawamoto HK, Bradley JP. Successful blood conservation during craniosynostotic correction with dual therapy using Procrit and cell saver. J Caraniofac Surg 2008;19:101-5.
17. Munoz M, Ariza D, Garceran MJ, Wald S, Lazareff J, Kawamoto HK, Bradley JP. Benefits of postoperative shed blood reinfusion in patients undergoing unilateral total knee replacement. Arch Orthop Trauma Surg. 2005;125:385-9.
18. Parker MJ, Livingstone V, Clifton R, McKee A. Closed suction surgical wound drainage after orthopaedic surgery. Cochrane Database Syst. Rev. 2007;18(3):CD001825.
19. Hazarika S, Bhattacharya R, Bhavikatti M, Dawson M. A comparison of post-op haemaglobin levels and allogenic blood transfusion rates following total knee arthroplasty without drainage or with reinfusion drains. Acta Orthop. Belg. 2010; 76:74-8.
20. Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE. Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. J Arthroplasty. 2014; 29(8):1512-5.
21. Yang ZG, Chen WP, Wu LD. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 2012; 94(13): 1153-59.
22. Ishida K, Tsumura N, Kitagawa A, Hamamura S, Fukuda K, Dogaki Y, Kubo S, Matsumoto T, Matsushita T, Chin T, Iguchi T, Kurosaka M, Kuroda R. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop. 2011; 35(11): 1639- 45.
23. Sarzaeem MM, Razi M, Kazemian G, Moghaddam ME, Rasi AM, Karimi M. Comparing efficacy of three methods of tranexamic acid administration in reducing haemaglobin drop following total knee arthroplasty. J Arthroplasty. 2014;29(8):1521.
24. Maniar RN, Kumar G, Singhi T, Nayak RM, Maniar PR. Most effective regimen of tranexamic acid in knee arthroplasty. A prospective randomized controlled study in 240 patients. Clin Orthop Relat Res. 2012;470(9):2605.
25. Randelli F, DAnchise R, Ragone V, Serrao L, Cabitza P, Randelli P. Is the newest fibrin sealant an effective strategy to reduce blood loss after total knee arthroplasty? A randomized controlled study. J Arthroplasty. 2014;29(8):1516-20.
26. Molloy DO, Archbold HA, Ogonda L, McConway J, Wilson RK, Beverland DE. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomized controlled trial. J Bone Joint Surg Br 2007; 89(3): 306-9.